The Global Amyotrophic Lateral Sclerosis Treatment Market was valued at USD 634 Million in 2023 and expected to grow USD 1021 Million in 2032.

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

Formerly known as Lou Gehrig’s disease, amyotrophic lateral sclerosis is now commonly ... waste away, and weaken. Symptoms from ALS start mild, like minor and limited muscle weakness, but ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration (USFDA) has granted Orphan Drug Designation (ODD) to Usnoflast, a ...

Brian Jeansonne and his wife Kristy open up about how they've used TikTok to find community after he was diagnosed with ALS in 2019.

An expansion of a hexanucleotide repeat in the C9ORF72 gene can cause ALS. Here, the authors develop a high-fidelity RNA-targeting CRISPR system to suppress the repeat RNA expressed from the ...

Roy and his wife, Jamie, asked Wake County to offer that lump sum to officers like him who medically retire but don’t ...

Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...

Primary lateral sclerosis is less common than amyotrophic lateral sclerosis, commonly called ALS. It's often mistaken for ALS, but the symptoms progress more slowly. In the majority of cases ...

Barbara Goodfriend, 83, opted for medical aid in dying after being diagnosed with ALS. The New Jersey widow ended her life in ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...